Search Results
Search results for "Institute for Research in Immunology and Cancer"
Results found for "Institute for Research in Immunology and Cancer"
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in class innovative cancer
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Significant resources have been invested into the search for small molecule modulators of small protein for a number of inflammatory diseases including atherosclerosis, scleroderma, multiple sclerosis and cancer The Future of GPCR Research GPCRs are a very important class of drug targets, but despite historical Orion has entered a strategic research collaboration with Peptilogics, a US-based AI drug discovery company and efficiently advance a diversified portfolio of GPCR-targeted drug candidates for the treatment of cancer
- 4GPCRnet - International Symposium
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
City-based Kallyope, pioneers in drug discovery involving the gut-brain axis, have entered a strategic research
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development and cancer
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
hypercalcemia caused by biased allosteric CaSR autoantibodies "Biased agonism is a frontier field in GPCR research
- GPCR Happy Hour – Boston, Sept 2025
Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- TeachOpenCADD - A teaching platform for computer-aided drug design
both the theoretical as well as practical aspect of these topics, the platform addresses students and researchers
- Radioligands vs. Fluorescent Ligands: Binding Assays
Understanding receptor-ligand interaction is key in drug discovery and biomedical research.
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Informatics Expands the Search Space for Chemical Drug Matter Advances in chemoinformatics  introduced Peptide GPCR therapies now address obesity, diabetes, cancer, neuroendocrine disorders, inflammatory
- GPCRs at Discovery on Target 2026
Zhang is a structural biologist with more than two decades in small molecule research across oncology
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM) cells by RT-PCR, immunoblotting
- Do You Believe AI Could Accelerate Drug Discovery?
screening and large-scale data analysis, paving the way for a new era in precision medicine and medical research
- Platelets in the NETworks interweaving inflammation and thrombosis
Research over the past years has provided a substantial body of evidence demonstrating that platelets
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Position your research for maximum visibility. Â
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
signaling pathway, which is involved in embryonic development and is implicated in various types of cancer
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
from odor perception, and may contribute to the pathogenesis of disorders including brain diseases and cancers
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
In Episode 3 of 3 Â of our series with Celtarys Research , leaders from academia and biotech unpack what
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Despite intensive research, a known treatment for MS disease yet to be introduced.
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
communication rhythm: internal alignment weekly cross-functional integration biweekly investor check-ins
- New role of β-arrestins in MOR signaling
According with the National Institute on Drug Abuse (NIDA) nearly 92, 000 Americans died from drug-involved
- Amylin Receptor Signaling: Three Receptors From One, and How to Profile Each
quantitative readouts of ligand activity across both cAMP signaling and β-arrestin recruitment, allowing researchers
- Overview of adhesion GPCRs self-activation
Different studies have shown that aGPCRs such as Lphns have promiscuous behavior, where in a constitutive knowing the factors that determine the selectivity of coupling represents a very interesting area of research
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
In conclusion, GPCR priming represents a compelling area of research that promises to deepen our understanding
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
This research further clarified the underlying role of β-arrestin2 and provided an experimental foundation
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
More research into the endocannabinoid system (ECS) will let us access these GPCRs in a safer manner
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
matters: Allosteric inhibitors often retain potency under high substrate conditions, such as ATP-rich cancer














